X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.90 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Current Deferred Revenue (2025 - 2026)

Updated

X4 Pharmaceuticals (XFOR) recorded Current Deferred Revenue of $842,000 in Q2 2026, up 11.7% from $754,000 a year earlier but down 7.5% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, X4 Pharmaceuticals reported Current Deferred Revenue of $464,000.

  • Quarterly Current Deferred Revenue has ranged from $464,000 in Q4 2025 to $910,000 in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $910,000 (Q1 2026), $464,000 (Q4 2025) and $592,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 X4 Pharmaceuticals 366.40 Mn -332.29 Mn 7.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 842,000.00
Mar 31, 2026 910,000.00
Dec 31, 2025 464,000.00
Sep 30, 2025 592,000.00
Jun 30, 2025 754,000.00
Mar 31, 2025 855,000.00
API Access

X4 Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=XFOR&period=max&api_key=YOUR_API_KEY